2022 Guide to Patient Support Services

Puma Biotechnology

Puma Biotechnology Support Services

855-816-5421

Puma Biotechnology offers Puma Patient Lynx to assist patients while taking Nerlynx (Table).

Puma Patient Lynx Program

In addition to benefit verification, prior authorization assistance, and support for patients with financial needs, the Puma Patient Lynx program offers the following access and reimbursement services:

  • Nerlynx Quick Start provides a free 3-week supply of Nerlynx to eligible patients experiencing delays in accessing Nerlynx therapy
  • Nerlynx Co-Pay Card is available for eligible, commercially insured patients (see below for details).

The Puma Patient Lynx program also offers the following ongoing treatment support services:

  • Nerlynx Mentor Program provides patient mentors to other patients who are considering or currently taking Nerlynx
  • Nurse Call Center is available for patients and healthcare providers to answer questions about Nerlynx. Nurses are available Monday to Friday from 9 am to 8 pm ET at 855-816-5421. Bilingual nurses are available
  • Text Message Support Program is available for patients who would like to receive medication reminders and motivational text messages
  • Supportive Care Voucher Program provides 3 months’ free supply of antidiarrheal products to all patients taking Nerlynx.

Click here to learn more or to enroll your patient in Puma Patient Lynx, or call 855-816-5421.

Nerlynx Co-Pay Card

Puma Biotechnology offers copay assistance to help patients with out-of-pocket costs associated with their prescription. To be eligible, patients must:

  • Have a prescription for Nerlynx
  • Have commercial insurance
  • Not participate in Medicare, Medicaid, or any other federal or state program
  • Not seek reimbursement for Nerlynx from a third-party payer such as a flexible spending account, a healthcare savings account, or a health reimbursement account.

Click here to learn more or to enroll your patient in the Nerlynx Co-Pay Savings Program, or call 855-816-542.

TABLE Puma Biotechnology Oncology Drug

Drug
Indications
Patient support programs

Drug
Nerlynx (neratinib) tablets
Indications
Extended adjuvant treatment of adults with early-stage HER2-positive breast cancer, after adjuvant trastuzumab-based therapy; treatment, in combination with capecitabine, of advanced or metastatic HER2-positive breast cancer in adults, after ≥2 HER2-targeted regimens in the metastatic setting
Patient support programs

Report Broken Links

Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?

Help us fix it! Report broken links here.

Report Broken Links

Report Broken Links

*OPM Webpage
Please copy the URL (link) of the OPM webpage you are currently on.
*Broken Link
Please copy the URL (link) to the external webpage that is not displaying content correctly.
Errors include, but are not limited to:
  • "This site can’t be reached"
  • "Hmm. We’re having trouble finding that site."
  • "Hmmm… can't reach this page"
  • "404 Error: Page not found"
Comments
(Optional)